Nadia Velázquez-Hernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nadia Velázquez-Hernández has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Erick Ordoñez-Villordo
Faculty of Medicine, Puebla State University of Health, Puebla of Zaragoza 72000, Mexico
1 shared publication - Erika Gómez-Zamora
Department of Medical Management, Hospital Juarez of Mexico, Mexico City 07760, Mexico
1 shared publication - Fani Villa-Rivas
Faculty of Nursing and Midwifery, Juarez University of the State of Durango, Durango 34217, Mexico
1 shared publication - José Ángel Hernández-Mariano
Departamento de Docencia e Investigación en Enfermería, Instituto Nacional de Cancerología, Mexico City 14080, Mexico
1 shared publication - Juan Carlos Fernando Sánchez-Velázquez
Nursing School, Hospital Juárez de México, Mexico City 06090, Mexico
1 shared publication - Miguel Martínez-Trujillo
General Hospital with Family Medicine Unit Number 7, Mexican Social Security Institute, Cuautla 62740, Mexico
1 shared publication
Latest Publications
- Open Access
- 29 January 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (2) , 32
Age at Menarche and Risk of Hypertensive Disorders of Pregnancy: A Retrospective Cohort Study
Background/Objectives: Hypertensive disorders of pregnancy (HDP) remain a major contributor to maternal morbidity and mortality worldwide, yet early-life reproductive factors such as age at menarche have been insufficiently explored in relation to HDP. Therefore, we aimed to evaluate the association between age at menarche and the risk of HDP in a cohort of Mexican pregnant women. Methods: We conducted a retrospective cohort study among 1344 women with singleton pregnancies receiving care at a tertiary hospital in Mexico City in 2024. Age at menarche was categorized as 14 years. HDP diagnoses were extracted from clinical records. Poisson regression with robust variance was used to estimate adjusted risk ratios (RRs). Sensitivity analyses included alternative menarche categorizations and restricted cubic spline models. Counterfactual mediation analyses assessed indirect effects through reconstructed prepregnancy BMI and gestational diabetes. Results: Both early (14 years) menarche were associated with higher HDP risk than the 12–14-year reference (adjusted RR = 1.81; 95% CI 1.42–2.30, and 1.74; 95% CI 1.27–2.38, respectively). Spline models confirmed a U-shaped association. Mediation analyses indicated that prepregnancy BMI did not meaningfully mediate the association for either early or late menarche (<5% mediated). Gestational diabetes explained a modest proportion of the association for early menarche (≈14%), but not for late menarche. Conclusions: Age at menarche showed a robust U-shaped association with HDP, mostly independent of adiposity and gestational diabetes, within the limits of the available measurements. Incorporating pubertal timing into routine reproductive history taking may enhance contextual risk assessment for HDP.
- 29 January 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (2) , 32
Open AccessAge at Menarche and Risk of Hypertensive Disorders of Pregnancy: A Retrospective Cohort Study
Background/Objectives: Hypertensive disorders of pregnancy (HDP) remain a major contributor to maternal morbidity and mortality worldwide, yet early-life reproductive factors such as age at menarche have been insufficiently explored in relation to HDP. Therefore, we aimed to evaluate the association between age at menarche and the risk of HDP in a cohort of Mexican pregnant women. Methods: We conducted a retrospective cohort study among 1344 women with singleton pregnancies receiving care at a tertiary hospital in Mexico City in 2024. Age at menarche was categorized as 14 years. HDP diagnoses were extracted from clinical records. Poisson regression with robust variance was used to estimate adjusted risk ratios (RRs). Sensitivity analyses included alternative menarche categorizations and restricted cubic spline models. Counterfactual mediation analyses assessed indirect effects through reconstructed prepregnancy BMI and gestational diabetes. Results: Both early (14 years) menarche were associated with higher HDP risk than the 12–14-year reference (adjusted RR = 1.81; 95% CI 1.42–2.30, and 1.74; 95% CI 1.27–2.38, respectively). Spline models confirmed a U-shaped association. Mediation analyses indicated that prepregnancy BMI did not meaningfully mediate the association for either early or late menarche (<5% mediated). Gestational diabetes explained a modest proportion of the association for early menarche (≈14%), but not for late menarche. Conclusions: Age at menarche showed a robust U-shaped association with HDP, mostly independent of adiposity and gestational diabetes, within the limits of the available measurements. Incorporating pubertal timing into routine reproductive history taking may enhance contextual risk assessment for HDP.